Tumour necrosis factor (TNF) soluble receptors in malignant melanoma: Correlation with soluble ICAM-1 level

This publication has 17 references indexed in Scilit:

• Soluble tumour necrosis factor receptors as prognostic factors in cancer patients
  The Lancet, 1994
• Differential Effects of Interleukin 1-α (IL-1α) or Tumor Necrosis Factor-α (TNF-α) on Motility of Human Melanoma Cell Lines on Fibronectin
  Journal of Investigative Dermatology, 1994
• Immunosuppressive Effect of Shedding Intercellular Adhesion Molecule 1 Antigen on Cell‐mediated Cytotoxicity against Tumor Cells
  Japanese Journal of Cancer Research, 1994
• Serum soluble tumour necrosis factor receptor 55 is increased in patients with haematological neoplasias and is associated with immune activation and weight loss
  European Journal Of Cancer, 1993
• Soluble intercellular adhesion molecule 1 (sICAM-1) and malignant melanoma
  Cancer Letters, 1993
• Two TNF receptors
  Immunology Today, 1992
• Circulating Intercellular Adhesion Molecule 1 as a Marker of Disease Progression in Cutaneous Melanoma
  New England Journal of Medicine, 1992
• High levels of circulating soluble receptors for tumor necrosis factor in hairy cell leukemia and type B chronic lymphocytic leukemia.
  Journal of Clinical Investigation, 1992
• Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans
  Cytokine, 1990
• Peptide Regulatory Factors
  The Lancet, 1989